DIN 02538237 — XYWAV 0.04 G; 0.096 G; 0.234 G; 0.13 G
XYWAV is a solution of Calcium Oxybate / Magnesium Oxybate / Potassium Oxybate / Sodium Oxybate marketed by JAZZ PHARMACEUTICALS IRELAND LIMITED. The full Calcium Oxybate / Magnesium Oxybate / Potassium Oxybate / Sodium Oxybate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02538237
- Brand name
- XYWAV
- Strength
- 0.04 G; 0.096 G; 0.234 G; 0.13 G
- Dosage form
- SOLUTION
- Route
- ORAL
- Manufacturer
- JAZZ PHARMACEUTICALS IRELAND LIMITED
- Health Canada status
- MARKETED
- Drug class
- Central nervous system depressant (mixed oxybate salts / gamma-hydroxybutyrate)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.